[Toxicological studies of N-4-2-(5-chloro-2-methoxybenzamido)-ethyl-phenylsulfonyl-n'-cyclohexylurea (HB 419)].
D000014:Abnormalities, Drug-Induced; D000311:Adrenal Glands / Q000187:drug effects; D000818:Animals; D001769:Blood / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000187:drug effects; D005835:Genitalia / Q000187:drug effects; D006128:Growth / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008297:Male; D051379:Mice; D010902:Pituitary Gland / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D012863:Skeleton / Q000187:drug effects; D013154:Spleen / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects; D013961:Thyroid Gland / Q000187:drug effects; D014508:Urea / Q000633:toxicity*
D007004:Hypoglycemic Agents; D014508:Urea
Toxikologische Untersuchung von N-4-2-(5-Chlor-2-methoxybenzamido)-acethyl-phenylsulfonyl-N'-cyclohexylharnstoff (HB 419)